TENOXICAM DIN 02230510
Health Canada record
| Active ingredient(s) | TENOXICAM 20 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M01AC02 TENOXICAM |
| Original market date | |
| Current status date | 16-Sep-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TENOXICAM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00884367 | MOBIFLEX TAB 20MG | HOFFMANN-LA ROCHE LIMITED | Tablet | TENOXICAM 20 MG | Cancelled Post Market |
| 02231314 | NOVO-TENOXICAM TAB 20MG | NOVOPHARM LIMITED | Tablet | TENOXICAM 20 MG | Cancelled Post Market |
| 02230661 | TENOXICAM | AA PHARMA INC | Tablet | TENOXICAM 20 MG | Dormant |
| 02231120 | TENOXICAM-20 | PRO DOC LIMITEE | Tablet | TENOXICAM 20 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 26660 | 2021-09-16 | New Drug Submission (NDS) | Transfer of Product Ownership. Updates to Product Monograph. Updates to Bottle Labels. Change in Brand Name |
| 4138 | 1997-01-24 | New Drug Submission (NDS) |
International API supply for TENOXICAM
1 valid EDQM Certificates of Suitability from 1 holders.
Request a quote for TENOXICAM